72 related articles for article (PubMed ID: 31807064)
1. Claudin-12 Deficiency Inhibits Tumor Growth by Impairing Transendothelial Migration of Myeloid-Derived Suppressor Cells.
Cao H; Ni C; Han L; Wang R; Blasig R; Haseloff R; Qin Y; Lan J; Lou X; Ma P; Yao X; Wang L; Wang F; Zhu L; Lei N; Blasig IE; Qin Z
Cancer Res; 2022 Jul; 82(13):2472-2484. PubMed ID: 35580275
[TBL] [Abstract][Full Text] [Related]
2. The Expression of the Claudin Family of Proteins in Colorectal Cancer.
Cox KE; Liu S; Hoffman RM; Batra SK; Dhawan P; Bouvet M
Biomolecules; 2024 Feb; 14(3):. PubMed ID: 38540693
[TBL] [Abstract][Full Text] [Related]
3. Expression patterns of claudins in cancer.
Tao D; Guan B; Li H; Zhou C
Heliyon; 2023 Nov; 9(11):e21338. PubMed ID: 37954388
[TBL] [Abstract][Full Text] [Related]
4. Claudin and pancreatic cancer.
Wang C; Wu N; Pei B; Ma X; Yang W
Front Oncol; 2023; 13():1136227. PubMed ID: 36959784
[TBL] [Abstract][Full Text] [Related]
5. LINC00857 regulated by ZNF460 enhances the expression of CLDN12 by sponging miR-150-5p and recruiting SRSF1 for alternative splicing to promote epithelial-mesenchymal transformation of pancreatic adenocarcinoma cells.
Zhang Y; Fang Y; Ma L; Xu J; Lv C; Deng L; Zhu G
RNA Biol; 2022; 19(1):548-559. PubMed ID: 35442145
[TBL] [Abstract][Full Text] [Related]
6. Identification of a 7-mRNA signature as a prognostic biomarker in pediatric osteosarcoma.
Cui T; Guo J; Jin C
Transl Cancer Res; 2020 Nov; 9(11):6733-6742. PubMed ID: 35117283
[TBL] [Abstract][Full Text] [Related]
7. Development of a Machine Learning-Based Autophagy-Related lncRNA Signature to Improve Prognosis Prediction in Osteosarcoma Patients.
Zhang GZ; Wu ZL; Li CY; Ren EH; Yuan WH; Deng YJ; Xie QQ
Front Mol Biosci; 2021; 8():615084. PubMed ID: 34095215
[TBL] [Abstract][Full Text] [Related]
8. Tight Junction Protein Claudin-12 Is Involved in Cell Migration during Metastasis.
Kolchakova D; Moten D; Batsalova T; Dzhambazov B
Biomolecules; 2021 Apr; 11(5):. PubMed ID: 33922921
[TBL] [Abstract][Full Text] [Related]
9. HER4 promotes the growth and metastasis of osteosarcoma via the PI3K/AKT pathway.
Li X; Huang Q; Wang S; Huang Z; Yu F; Lin J
Acta Biochim Biophys Sin (Shanghai); 2020 Apr; 52(4):345-362. PubMed ID: 32181480
[TBL] [Abstract][Full Text] [Related]
10. The Cytoplasmic Expression Of CLDN12 Predicts An Unfavorable Prognosis And Promotes Proliferation And Migration Of Osteosarcoma.
Tian X; He Y; Han Z; Su H; Chu C
Cancer Manag Res; 2019; 11():9339-9351. PubMed ID: 31807064
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of carboxypeptidase X M14 family member 2 predicts an unfavorable prognosis and promotes proliferation and migration of osteosarcoma.
Zhao X; Li R; Wang Q; Wu M; Wang Y
Diagn Pathol; 2019 Oct; 14(1):118. PubMed ID: 31651348
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of claudin-12 promotes the metastatic phenotype of human bronchial epithelial cells and is associated with poor prognosis in lung squamous cell carcinoma.
Sun L; Feng L; Cui J
Exp Ther Med; 2019 Jan; 17(1):165-174. PubMed ID: 30651778
[TBL] [Abstract][Full Text] [Related]
13. AIM2 inhibits the proliferation, invasion and migration, and promotes the apoptosis of osteosarcoma cells by inactivating the PI3K/AKT/mTOR signaling pathway.
Zheng J; Liu C; Shi J; Wen K; Wang X
Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34913077
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of long non-coding RNA DBH-AS1 inhibits osteosarcoma progression by PI3K-AKT signaling pathways and indicates good prognosis.
Liu ZB; Wang JA; Lv RQ
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1418-1427. PubMed ID: 30840262
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
